Phase II Study of Weekly Paclitaxel in Patients with Non-Small Cell Lung Cancer Who Have Failed Previous Treatments

Kazuhito Yasuda,Tadashi Igishi,Yuji Kawasaki,Kato K,Shingo Matsumoto,Satoru Katayama,Takanori Sako,Yasushi Shigeoka,Hisashi Suyama,Akinori Sugitani,Mistunobu Yamamoto,Yutaka Hitsuda,Eiji Shimizu

Phase II Study of Weekly Paclitaxel in Patients with Non-Small Cell Lung Cancer Who Have Failed Previous Treatments

2004

Kazuhito Yasuda
Tadashi Igishi
Yuji Kawasaki
Kato K
Shingo Matsumoto
Satoru Katayama
Takanori Sako
Yasushi Shigeoka
Hisashi Suyama
Akinori Sugitani
Mistunobu Yamamoto
Yutaka Hitsuda
Eiji Shimizu

Objective: New effective therapy is desirable for patients with non-small cell lung cancer (NSCLC) who have failed previous treatments. Fractionated administration of paclitaxel may

Keywords:

Pathology
Phases of clinical research
Respiratory disease
Immunology
Cancer
Medicine
Survival analysis
Paclitaxel
Lung cancer
Progressive disease
Adverse effect
Pneumonitis
Leukopenia

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations